{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:18:18Z","timestamp":1749010698742,"version":"3.41.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01MD016838"],"award-info":[{"award-number":["R01MD016838"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA043204","R01DA011792","R00DA049886"],"award-info":[{"award-number":["R01DA043204","R01DA011792","R00DA049886"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH018921"],"award-info":[{"award-number":["T32MH018921"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.dadr.2025.100325","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:45:08Z","timestamp":1742319908000},"page":"100325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-8362","authenticated-orcid":false,"given":"Kerry L.","family":"Kinney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseu","family":"da Cruz Moreira-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00eds F.","family":"Berro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2025.100325_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100325_bib2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1176\/appi.ps.201500380","article-title":"Sustained use of benzodiazepines and escalation to high doses in a Canadian population","volume":"67","author":"Alessi-Severini","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.dadr.2025.100325_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4088\/JCP.20m13283","article-title":"Coprescribed benzodiazepines in older adults receiving antidepressants for anxiety and depressive disorders: association with treatment outcomes","volume":"81","author":"Altmann","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"American Geriatrics Society Beers Criteria Update Expert Panel","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.dadr.2025.100325_bib5","series-title":"Annales Pharmaceutiques Francaises","first-page":"408","article-title":"Benzodiazepine dependence: focus on withdrawal syndrome","author":"Authier","year":"2009"},{"key":"10.1016\/j.dadr.2025.100325_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145701002632","article-title":"Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Bagdy","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. stat. soc.: ser. B (Methodol.)"},{"key":"10.1016\/j.dadr.2025.100325_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.pbb.2011.03.006","article-title":"Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB\/c mice","volume":"98","author":"Birkett","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.dadr.2025.100325_bib9","series-title":"StatPearls [Internet]","article-title":"Benzodiazepines","author":"Bounds","year":"2023"},{"key":"10.1016\/j.dadr.2025.100325_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs RD"},{"key":"10.1016\/j.dadr.2025.100325_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40261-018-0648-y","article-title":"Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting","volume":"38","author":"Brandt","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.dadr.2025.100325_bib12","first-page":"747","article-title":"Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001-2014","volume":"74","author":"Bushnell","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2025.100325_bib13","doi-asserted-by":"crossref","first-page":"37519","DOI":"10.4088\/JCP.20m13863","article-title":"Simultaneous benzodiazepine and SSRI initiation in young people with anxiety disorders","volume":"82","author":"Bushnell","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/cn5000056","article-title":"Classics in chemical neuroscience: diazepam (valium)","volume":"5","author":"Calcaterra","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.dadr.2025.100325_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","article-title":"Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse","volume":"187","author":"Cook","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100325_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2023.09.002","article-title":"Race, economic status, and disparities in the receipt of benzodiazepine prescriptions in a large primary care sample","author":"Dore","year":"2023","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4088\/PCC.v10n0307","article-title":"Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review","volume":"10","author":"Dunlop","year":"2008","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.dadr.2025.100325_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00195913","article-title":"A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine","volume":"46","author":"Fleishaker","year":"1994","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-0327(00)00254-8","article-title":"Is antidepressant\u2013benzodiazepine combination therapy clinically more useful?: a meta-analytic study","volume":"65","author":"Furukawa","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.dadr.2025.100325_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004714-198710000-00007","article-title":"An open trial of fluoxetine in the treatment of panic attacks","volume":"7","author":"Gorman","year":"1987","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(95)98597-J","article-title":"5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research","volume":"65","author":"Griebel","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.dadr.2025.100325_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.npp.1301204","article-title":"A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study","volume":"32","author":"Grillon","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dadr.2025.100325_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.dadr.2025.100325_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/pds.1920","article-title":"General exposures to prescription medications by race\/ethnicity in a population-based sample: results from the Boston Area Community Health Survey","volume":"19","author":"Hall","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.dadr.2025.100325_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12991-016-0115-1","article-title":"Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial","volume":"15","author":"Hashimoto","year":"2016","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1185\/030079905X48401","article-title":"Benzodiazepines and anxiety disorders: a review for the practicing physician","volume":"21","author":"Kaplan","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.dadr.2025.100325_bib28","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2025.100325_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib30","first-page":"167","article-title":"Benzodiazepine dependence and withdrawal: identification and medical management","volume":"5","author":"Landry","year":"1992","journal-title":"J. Am. Board Fam. Pract."},{"key":"10.1016\/j.dadr.2025.100325_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/clpt.1988.52","article-title":"The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam","volume":"43","author":"Lemberger","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.dadr.2025.100325_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.dadr.2025.100325_bib33","first-page":"205","article-title":"Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features","volume":"2","author":"Marken","year":"2000","journal-title":"Prim. care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.dadr.2025.100325_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-004-2009-1","article-title":"Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure","volume":"178","author":"Mintzer","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.dadr.2025.100325_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s002130051161","article-title":"A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users","volume":"147","author":"Mintzer","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.dadr.2025.100325_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/npr2.12379","article-title":"Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two-year period of pharmacotherapy","volume":"44","author":"Mori","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.dadr.2025.100325_bib38","doi-asserted-by":"crossref","unstructured":"Nezlek, J.B., 2012. Multilevel modeling for psychologists.","DOI":"10.1037\/13621-011"},{"key":"10.1016\/j.dadr.2025.100325_bib39","unstructured":"NIDA, 2024. Drug Overdose Deaths: Facts and Figures."},{"key":"10.1016\/j.dadr.2025.100325_bib40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamapsychiatry.2022.1150","article-title":"Complex persistent benzodiazepine dependence\u2014when benzodiazepine deprescribing goes awry","volume":"79","author":"Peng","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib41","first-page":"113","article-title":"Benzodiazepines and related sedatives","volume":"106","author":"Peng","year":"2022","journal-title":"Med. Clin."},{"key":"10.1016\/j.dadr.2025.100325_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsp.2009.09.002","article-title":"A practical guide to multilevel modeling","volume":"48","author":"Peugh","year":"2010","journal-title":"J. Sch. Psychol."},{"key":"10.1016\/j.dadr.2025.100325_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/02698811030173009","article-title":"Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder","volume":"17","author":"Pollack","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3102\/10769986031004437","article-title":"Computational tools for probing interactions in multiple linear regression, multilevel modeling, and latent curve analysis","volume":"31","author":"Preacher","year":"2006","journal-title":"J. Educ. Behav. Stat."},{"year":"2019","series-title":"HLM 8: Linear and nonlinear modeling","author":"Raudenbush","key":"10.1016\/j.dadr.2025.100325_bib45"},{"key":"10.1016\/j.dadr.2025.100325_bib46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s40615-021-01224-z","article-title":"Racial-ethnic disparities in benzodiazepine prescriptions for anxiety in US Emergency Departments","volume":"10","author":"Ribas Roca","year":"2023","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"10.1016\/j.dadr.2025.100325_bib47","first-page":"20230075","article-title":"Long-term use of benzodiazepines and benzodiazepine-related drugs: a register-based danish cohort study on determinants and risk of dose escalation","author":"Rosenqvist","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib48","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archpsyc.62.11.1249","article-title":"Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults","volume":"62","author":"Sareen","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0376-8716(93)90018-L","article-title":"Withdrawal symptoms from high dose benzodiazepines in poly drug users","volume":"32","author":"Seivewright","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100325_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1060028016682530","article-title":"Benzodiazepine initiation and dose escalation: a risk factor for inpatient falls","volume":"51","author":"Skinner","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.dadr.2025.100325_bib51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1176\/ajp.155.10.1339","article-title":"Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study","volume":"155","author":"Smith","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib52","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/appi.ps.54.7.1006","article-title":"Lack of relationship between long-term use of benzodiazepines and escalation to high dosages","volume":"54","author":"Soumerai","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.dadr.2025.100325_bib53","first-page":"29","article-title":"Comorbidity in generalized anxiety disorder: impact and implications","volume":"62","author":"Stein","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib54","doi-asserted-by":"crossref","DOI":"10.12788\/cp.0365","article-title":"Optimizing benzodiazepine treatment of anxiety disorders: Understanding the pharmacology of these agents can help guide medication selection and dosing","volume":"22","author":"Strawn","year":"2023","journal-title":"Curr. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100325_bib55","first-page":"12","volume":"32","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"10.1016\/j.dadr.2025.100325_bib56","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00228-003-0563-9","article-title":"Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles","volume":"58","author":"Suzuki","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003296","article-title":"A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing","volume":"3","author":"Tvete","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.dadr.2025.100325_bib58","unstructured":"University of Mississippi Medical Center, C. for I. and A., 2020. Patient Cohort Explorer (PCE). https:\/\/doi.org\/10.6084\/m9.figshare.12252737.v2"},{"key":"10.1016\/j.dadr.2025.100325_bib59","first-page":"90","article-title":"Side effects of treatment with benzodiazepines","volume":"22","author":"Uzun","year":"2010","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.dadr.2025.100325_bib60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00228-002-0548-0","article-title":"Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up","volume":"58","author":"Van Hulten","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00228-007-0341-1","article-title":"Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation","volume":"63","author":"Veronese","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2025.100325_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000139363","article-title":"Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics","volume":"51","author":"Vgontzas","year":"1995","journal-title":"Pharmacology"},{"key":"10.1016\/j.dadr.2025.100325_bib63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","article-title":"The history of benzodiazepines","volume":"28","author":"Wick","year":"2013","journal-title":"Consult. Pharm. \u00ae"},{"key":"10.1016\/j.dadr.2025.100325_bib64","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/fampra\/cmt010","article-title":"Tolerance to benzodiazepines among long-term users in primary care","volume":"30","author":"Willems","year":"2013","journal-title":"Fam. Pract."},{"key":"10.1016\/j.dadr.2025.100325_bib65","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jecm.2012.10.007","article-title":"Evaluating the association of initial benzodiazepine use and antidepressant adherence among adults with anxiety disorders","volume":"4","author":"Wu","year":"2012","journal-title":"J. Exp. Clin. Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:54:29Z","timestamp":1748994869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":65,"alternative-id":["S2772724625000083"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100325","relation":{},"ISSN":["2772-7246"],"issn-type":[{"type":"print","value":"2772-7246"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Vanderbilt University Medical Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100325"}}